Embecta Corp. (EMBC) Revenue Growth
Embecta Corp. (EMBC) year-over-year revenue growth rate history. Analyze revenue growth in Excel with MarketXLS.
Revenue Growth Data
| Period | YoY Revenue Growth |
|---|---|
| 2023-09-30 | -0.77% |
| 2024-09-30 | 0.21% |
| 2025-09-30 | -3.80% |
How EMBC compares with sector peers
| Symbol | Company | Revenue growth (latest fiscal year) |
|---|---|---|
| BIO | Bio-Rad Laboratories Inc. Class A | 0.65% |
| MYGN | Myriad Genetics Inc. | -1.56% |
| NEOG | Neogen Corporation | -2.71% |
| PRGO | Perrigo Company plc | -2.75% |
| OGN | Organon & Co. | -2.92% |
These are five companies in the same sector as EMBC with a comparable annual revenue growth. Each figure above is that company's most recent completed fiscal year, read from the same annual statements as the table on its own page, so the period end dates can differ between rows.
Get Embecta Corp. Data in Excel
Stream real-time stock prices and financials directly into your spreadsheets with MarketXLS.
Try: =hf_Revenue_Growth("EMBC", 2024)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Volume |
| 2 | EMBC | $5.25 | +2.14% | 2.09M |
| 3 | ||||
| 4 | ||||
| 5 |